Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma

Area of Science:

• Oncology
• Immunology
• Pathology

Background:

• Immune checkpoint blockade (ICB) shows promise in treating malignancies like melanoma.
• Tumor-infiltrating lymphocytes (TIL) are crucial for predicting immunotherapy response and disease progression.

Purpose of the Study:

• To review TIL profiling in cutaneous melanoma using histopathological methods.
• To highlight the prognostic and predictive value of TIL subsets in melanoma patients.

Main Methods:

• Analysis of studies correlating TIL subsets (T cells, B cells, regulatory T cells) with patient survival.
• Review of tertiary lymphoid structures (TLS) in the tumor microenvironment (TME).
• Discussion of emerging technologies like digital pathology and imaging mass cytometry for TIL profiling.

Main Results:

• TIL numbers, localization, and phenotypes are key indicators of immunotherapy response and survival.
• Specific TIL subsets and tertiary lymphoid structures (TLS) are associated with improved patient outcomes.
• Existing literature primarily relies on single-marker immunohistochemistry for TIL enumeration.

Conclusions:

• TIL profiling is essential for understanding melanoma progression and predicting treatment efficacy.
• Advanced profiling techniques promise to revolutionize tumor immunopathology and patient care.
• Further research into TIL subsets and novel profiling methods can improve melanoma patient outcomes.